1Mon·

$CVS (+2.17%)

CVS Health ♥️

attachment



CVS Health Corp. describes itself as a diversified healthcare provider.

CVS Health Corporation offers various services in the medical field.

The company operates one of the largest pharmacy chains in the US and is also active in prescription management, health clinics and digital health services.

CVS Health is also known for its MinuteClinic health clinics, which can be found in many of its retail locations.


Key Figures:


Despite the recent fall in the share price, CVS Health shows solid key financial figures:


Profit:


CVS Health impresses with its extremely reliable profit development.


Over a 10-year period, CVS Health's earnings growth is 5.5% per year. However, analysts expect a decline in profits for the current financial year.


The current P/E ratio (price/earnings ratio) is 11.33, which is 0.63 points below the historical average of 11.96 for the last 10 years. From this perspective, the CVS Health share appears to be favorably valued.


Dividend:


With a dividend yield of 4.08% for 2024, the share remains attractive for investors.


CVS Health has been increasing its dividend for 3 years. Over the last 10 years, CVS Health has increased it by 9.47% annually. Over a 5-year period, the payout has risen by 6%.


CVS Health pays a dividend 4 times a year. The distribution months are February, May, August and November.


Current:


On October 18, 2024, David Joyner was appointed as the new CEO, replacing Karen Lynch. This surprising change in leadership comes at a time when the company is facing significant challenges.


I am curious to know what you think of CVS Health.

7
7 Comments

profile image
continues to run in my savings plan - still convinced by the share.
7
profile image
I like the breadth of the business segment very much, I am convinced of the turnaround and I got an impression of the business myself when I was in the USA. In my opinion, there is also more upside potential in the valuation than downside. I am curious to see how things will continue ✌️
4
profile image
Not a buy at the moment due to the disproportionate decline in sales and profits. But watchlist, as valuation level is now ok.
3
I joined the company on Friday and think the new CEO will get CVS back on track
1
View all 2 further answers
profile image
It is now up to the management and the new CEO, so no assessment at all.

Above all, they have to reduce debt, so the dividend doesn't matter for the time being.
1
Join the conversation